| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
s113 |
| issn |
1618-7598
1618-7601 |
| issueIdentifier |
Suppl 2 |
| pageRange |
s104-s113 |
| publicationName |
The European journal of health economics : HEPAC : health economics in prevention and care |
| startingPage |
s104 |
| bibliographicCitation |
Seshamani M. Is clozapine cost-effective? Unanswered issues. Eur J Health Econ. 2002 Nov;3 Suppl 2():S104–13. doi: 10.1007/s10198-002-0115-8. PMID: 15609156. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50b5f6acb86f540ca043ee2a89840e44 |
| date |
2002-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1007/s10198-002-0115-8
https://pubmed.ncbi.nlm.nih.gov/15609156 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1618-7601
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32127
https://portal.issn.org/resource/ISSN/1618-7598 |
| language |
English |
| source |
https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Is clozapine cost-effective? Unanswered issues |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398737
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9168 |